Fundraising Fox

Cresilon

Brooklyn, US · Delaware corporation · 3 known investors

cresilon.com ↗

Cresilon is a Brooklyn-based medical device company that develops plant-based hydrogel hemostatic products to rapidly stop bleeding. Its products include VETIGEL for veterinary use and the FDA-cleared TRAUMAGEL for controlling external traumatic bleeding in human trauma care.

BiotechHealthtechMedical Devicesin /cresilon@Cresilon

Founders & leadership

IM
Isaac MillerCo-founder
JL
Joseph LandolinaExecutive Officer, Director
SL
Scott LevineExecutive Officer
JL
Joe LandolinaCo-founder

Investors · 3

Catalio Capital Management, LPNew York
Dorm RoomBrooklyn · $90K – $250K
Innovating CapitalNew York · $10K – $3M

Reported raises · per SEC filings

Form D private placements
▶$29MraisedJun 2026 · 217 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Joseph LandolinaExecutive Officer, Director
  • Isaac MillerDirector
  • Scott LevineExecutive Officer
Offering amount
$29M
Amount sold
$29M
Minimum investment
$10K
Sales commissions
$3.4M
Placement agents
Paulson Investment Company, LLC
First sale
Apr 2026
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$6.7MraisedDec 2025 · 55 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Scott LevineExecutive Officer
  • Isaac MillerExecutive Officer, Director
  • Joseph LandolinaExecutive Officer, Director
Offering amount
$6.7M
Amount sold
$6.7M
Minimum investment
$25K
Sales commissions
$868.8K
Placement agents
Paulson Investment Company, LLC
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$17.2MraisedSep 2025 · 95 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Isaac MillerDirector
  • Joseph LandolinaExecutive Officer, Director
  • Scott LevineExecutive Officer
Offering amount
$34.8M
Amount sold
$17.2M
Minimum investment
$1.8K
Sales commissions
$2.2M
Placement agents
Paulson Investment Company, LLC
First sale
Apr 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25MraisedJan 2025 · 237 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Joseph LandolinaExecutive Officer, Director
  • Isaac MillerExecutive Officer, Director
  • Scott LevineExecutive Officer
Offering amount
$25M
Amount sold
$25M
Minimum investment
$5K
Sales commissions
$3.1M
Proceeds to insiders
$300K
Placement agents
Paulson Investment Company, LLC
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$17.2MraisedOct 2024 · 309 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Isaac MillerDirector
  • Scott LevineExecutive Officer
  • Joseph LandolinaExecutive Officer, Director
Offering amount
$38M
Amount sold
$17.2M
Minimum investment
$2.3K
Sales commissions
$2.2M
Placement agents
Paulson Investment Company, LLC
First sale
Aug 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25MraisedOct 2022 · 308 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Joseph LandolinaExecutive Officer, Director
  • Isaac MillerDirector
Offering amount
$25M
Amount sold
$25M
Minimum investment
$100K
Sales commissions
$3.2M
Proceeds to insiders
$200K
Placement agents
Paulson Investment Company, LLC
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$24.5MraisedFeb 2021 · 170 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph LandolinaExecutive Officer, Director
  • Isaac MillerExecutive Officer, Director
Offering amount
$45.3M
Amount sold
$24.5M
Minimum investment
$25K
Sales commissions
$2.8M
Placement agents
Paulson Investment Company, LLC
First sale
Jan 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.3MraisedJan 2018 · 55 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Isaac MillerExecutive Officer, Director
  • Joseph LandolinaExecutive Officer, Director
Offering amount
$19.3M
Amount sold
$13.3M
First sale
Dec 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.